Menstrual irregularities in PCOSDoes it matter when it starts?

Experimental and Clinical Endocrinology and Diabetes

Volumn 119, Issue 6, 2011, Pages 334-337

  Livadas, S ^a   Christou, M ^a   Economou, F ^a   Karachalios, A ^a   Xyrafis, X ^a   Boutzios, G ^a   Zerva, A ^a   Tantalaki, E ^a   Palimeri, S ^a   Diamanti Kandarakis, E ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

androgens; follicles; insulin resistance; oligomenorrhea; ovarian volume; polycystic ovary syndrome; ultrasound

Indexed keywords

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CROSS-SECTIONAL STUDY; FEMALE; HORMONAL REGULATION; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MENSTRUAL IRREGULARITY; MENSTRUATION DISORDER; METABOLIC BALANCE; ONSET AGE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PUBERTY; ULTRASOUND; BLOOD; CASE CONTROL STUDY; INSULIN RESISTANCE; PHYSIOLOGY; TIME;

GONADOTROPIN; LIPID; SEX HORMONE;

ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GONADAL STEROID HORMONES; GONADOTROPINS; HUMANS; INSULIN RESISTANCE; LIPIDS; MENSTRUATION DISTURBANCES; POLYCYSTIC OVARY SYNDROME; TIME FACTORS; YOUNG ADULT;

EID: 79958284562     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0030-1269882     Document Type: Article

References (22)

1. Apter D, Vihko R. Endocrine determinants of fertility: serum androgen concentrations during follow-up of adolescents into the third decade of life. J Clin Endocrinol Metab 1990 71 970-974
2. Apter D, Butzow T, Laughlin A et al,. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. J Clin Endocrinol Metab 1995 80 2966-2973
3. Avvad CK, Holeuwerger R, Silva CVG et al,. Menstrual irregularity in the first postmenarchal years: an early clinical sign of polycystic ovary syndrome in adolescence. Gynecol Endocrinol 2001 15 170-177 (Pubitemid 32640921)
4. Azziz R, Carmina E, Dewailly D et al,. Androgen Excess Society. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006 91 4237-4245 (Pubitemid 44833391)
5. Balen AH, Conway GS, Kaltsas G et al,. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 1995 10 2107-2111
6. Diamanti-Kandarakis E, Kouli CR, Bergiele AT et al,. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999 84 4006-4011 (Pubitemid 30644187)
7. Diamanti-Kandarakis E, Christakou C, Palioura E et al,. Does polycystic ovary syndrome start in childhood? Pediatr Endocrinol Rev 2008 5 904-911
8. Diamanti-Kandarakis E. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Expert Rev Mol Med 2008 10 e3
9. Diamanti-Kandarakis E, Piouka A, Livadas S et al,. Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome. Eur J Endocrinol 2009 160 847-853
10. Knochenhauer ES, Key TJ, Kahsar-Miller M et al,. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998 83 3078-3082 (Pubitemid 28500937)
11. Legro RS. Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev 2003 24 302-312 (Pubitemid 36724372)
12. Littlejohn E, Weiss R, Deplewski D et al,. Intractable early childhood obesity as the initial sign of insulin resistant hyperinsulinism and precursor of polycystic ovary syndrome. J Pediatr Endocrinol Metab 2007 20 41-51 (Pubitemid 46863537)
13. Rotterdam Consensus. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 2004 19 41-47
14. Shaw LJ, Bairey Merz CN, Azziz R et al,. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of HealthNational Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 2008 93 1276-1284 (Pubitemid 351519721)
15. Siegberg R, Nilsson CG, Stenman UH et al,. Endocrinologic features of oligomenorrheic adolescent girls. Fertil Steril 1986 46 852-857 (Pubitemid 17187659)
16. Solomon CG, Hu FB, Dunaif A et al,. Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. JAMA 2001 286 2421-2242
17. Solomon CG, Hu FB, Dunaif A et al,. Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab 2002 87 2013-2017 (Pubitemid 34521483)
18. Van Hoff MH, Voorhorst FJ, Kaptein MB et al,. Endocrine features of polycystic ovary syndrome in a random population sample of 1416 years old adolescence. Human Reproduction 1999 14 2223-2239
19. Van Hoff MH, Voorhorst FJ, Kaptein MB et al,. Polycystic ovaries in adolescents and the relationships with menstrual cycle patterns, lutenizing hormone, androgens, and isulin. Fertil Steril 2000 74 49-58 (Pubitemid 30427272)
20. van Hooff MH, Voorhorst FJ, Kaptein MB et al,. Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years. Hum Reprod 2004 19 383-392 (Pubitemid 38220012)
21. Venturoli S, Porcu E, Fabbri R et al,. Longitudinal evaluation of the different gonadotropin pulsatile patterns in anovulatory cycles of young girls. J Clin Endocrinol Metab 1992 74 836-841
22. Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: toward a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome Boston Blackwell Scientific Publications 1992 377-384